TIGIT and neoplasm: Dixon et al. [26] have demonstrated that a single TIGIT blockade in a murine model led to a modest inhibition of colon carcinoma growth, while the results of the PD-1 mAbs implementation alone were diverse, and a complete regression of the tumor was observed in only one animal out of a group of twelve mice.